Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at DeepMind Blog.
Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.
Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Biologists use Co-Scientist to find novel factors that successfully rejuvenate human cells.
arXiv:2607. 02944v1 Announce Type: cross Abstract: We propose PRECEDE, a precedent-guided co-scientist for side-effect-aware drug redesign that revises a parent compound to mitigate a specified side effect while preserving therapeutic function.
Accelerating the development of life-saving treatments.
